ArticleOpen forum infectious diseases2018

Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials.

Anirban Basu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.